Education
About Us
Working with TipRanks
Follow Us
Noile-Immune Biotech Inc. (JP:4893)
:4893
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 7.59M | ¥ 316.82M | ¥ 625.78M | ¥ 100.73M | ¥ 97.28M |
| Gross Profit | ¥ 7.39M | ¥ 314.56M | ¥ 618.71M | ¥ 77.83M | ¥ 94.31M |
| Operating Income | ¥ -1.07B | ¥ -775.39M | ¥ -106.34M | ¥ -767.51M | ¥ -604.48M |
| EBITDA | ¥ -1.07B | ¥ -775.39M | ¥ -106.34M | ¥ -767.51M | ¥ -591.67M |
| Net Income | ¥ -964.46M | ¥ -1.13B | ¥ -386.62M | ¥ -795.03M | ¥ -636.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 4.67B | ¥ 5.56B | ¥ 4.52B | ¥ 4.14B | ¥ 2.55B |
| Total Assets | ¥ 4.80B | ¥ 5.78B | ¥ 4.64B | ¥ 4.27B | ¥ 2.67B |
| Total Debt | ¥ 0.00 | ¥ 0.00 | ¥ 0.00 | ¥ 0.00 | ¥ 0.00 |
| Net Debt | ¥ -4.67B | ¥ -5.56B | ¥ -4.52B | ¥ -4.14B | ¥ -2.55B |
| Total Liabilities | ¥ 74.67M | ¥ 91.49M | ¥ 340.42M | ¥ 85.72M | ¥ 75.88M |
| Stockholders' Equity | ¥ 4.73B | ¥ 5.69B | ¥ 4.30B | ¥ 4.19B | ¥ 2.60B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -887.81M | ¥ -873.08M | ¥ -107.18M | ¥ -777.14M | ¥ -300.64M |
| Operating Cash Flow | ¥ -887.81M | ¥ -873.08M | ¥ -107.18M | ¥ -777.14M | ¥ -300.64M |
| Investing Cash Flow | ¥ 557.00K | ¥ -5.32M | ¥ 0.00 | ¥ -4.03M | ¥ 0.00 |
| Financing Cash Flow | ¥ 2.50M | ¥ 1.91B | ¥ 487.62M | ¥ 2.37B | ¥ 996.35M |